Cardiovascular disease and diabetes in HIV ‐positive and HIV‐negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation Study
ConclusionsHIV ‐positive GBM more commonly reported heart disease and thrombosis compared with their HIV‐negative peers. These results further highlight the need to understand the impact of HIV on age‐related comorbidities in GBM, to guide optimal screening and treatment strategies to reduce the risk of thes e comorbidities among the HIV‐positive population. (Source: HIV Medicine)
Source: HIV Medicine - November 26, 2018 Category: Infectious Diseases Authors: R Puhr, K Petoumenos, R Huang, DJ Templeton, I Woolley, M Bloch, D Russell, MG Law, DA Cooper Tags: Original Research Source Type: research

Lost but not forgotten: A population ‐based study of mortality and care trajectories among people living with HIV who are lost to follow‐up in Ontario, Canada
ConclusionsMortality risk and use of health care resources were lower among active cohort participants. Our findings may inform health outcome estimates based on volunteer cohorts, as well as quantitative bias adjustment to correct for such biases. (Source: HIV Medicine)
Source: HIV Medicine - November 26, 2018 Category: Infectious Diseases Authors: CE Kendall, J Raboud, J Donelle, M Loutfy, SB Rourke, A Kroch, C Liddy, R Rosenes, Ontario HIV Treatment Network (OHTN) Cohort Study Team, AN Burchell, Jeffrey Cohen, Don Kilby, Fred Crouzat, Nisha Andany, Nicole Mittmann, Irving Salit, Mi Tags: Original Research Source Type: research

Hepatic and renal toxicity and associated factors among HIV ‐infected children on antiretroviral therapy: a prospective cohort study
ObjectivesThe aim of the study was to investigate the prevalence of renal function and liver enzyme abnormalities among HIV ‐infected children, changes in prevalence with time on combination antiretroviral therapy (cART), and the factors associated with these abnormalities.MethodsA prospective cohort study was conducted among HIV ‐infected children 0.5, suggesting liver fibrosis. Being on a zidovudine (ZDV) ‐ or nevirapine (NVP)‐based regimen and having a viral load> 1000 HIV ‐1 RNA copies/mL were significantly associated with elevated ALT. Twenty‐four (3.4%) and 84 (12.1%) patients had elevated creatinine a...
Source: HIV Medicine - November 26, 2018 Category: Infectious Diseases Authors: BT Tadesse, BA Foster, A Kabeta, F Ayalew, G H/Meskel, D Jerene, E Makonnen, E Aklillu Tags: Original Research Source Type: research

Evolution of major non ‐HIV‐related comorbidities in HIV‐infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014
ObjectivesThe management of HIV disease is complicated by the incidence of a new spectrum of comorbid noncommunicable diseases (NCDs). It is important to document changes in the prevalence of NCDs over time. The aim of the study was to describe the impact of ageing on HIV markers and on the prevalence of NCDs in people living with HIV (PLWHIV) in the Italian Cohort of Individuals, Na ïve for Antiretrovirals (ICONA) seen for care in 2004–2014.MethodsAnalyses were conducted separately for a closed cohort (same people seen at both times) and an open cohort (all people under follow ‐up). We used the χ2 test fo...
Source: HIV Medicine - November 21, 2018 Category: Infectious Diseases Authors: A d'Arminio Monforte, H Diaz ‐Cuervo, A De Luca, F Maggiolo, A Cingolani, S Bonora, A Castagna, E Girardi, A Antinori, S Lo Caputo, G Guaraldi, A Cozzi‐Lepri, on behalf of the ICONA Foundation Study Group, F Castelli, R. Cauda, G. Perr Tags: Original Research Source Type: research

Prevalence and determinants of resistance mutations in HIV ‐1‐infected patients exposed to integrase inhibitors in a large Italian cohort
ConclusionsThe results support integrase resistance testing in INSTI ‐experienced patients. Emergence of INSTI resistance is facilitated by the reduced genetic barrier of the regimen as a consequence of resistance to companion drugs. However, INSTI resistance may become undetectable by standard population sequencing upon INSTI discontinuation. (Source: HIV Medicine)
Source: HIV Medicine - November 21, 2018 Category: Infectious Diseases Authors: S Modica, B Rossetti, F Lombardi, F Lagi, M Maffeo, R D'Autilia, M Pecorari, I Vicenti, B Bruzzone, G Magnani, S Paolucci, D Francisci, G Penco, D Sacchini, M Zazzi, A De Luca, A Di Biagio Tags: Original Research Source Type: research

Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV ‐infected patients in clinical practice: results from a multicentre, observational study
ObjectivesThe aim of the study was to compare the efficacy and tolerability of switching antiretroviral therapy to dolutegravir + emtricitabine/tenofovir disoproxil fumarate (TDF) with those of switching to elvitegravir/cobicistat/emtricitabine/TDF in clinical practice.MethodsIn a multicentre real ‐life observational study, we analysed data for HIV‐infected patients on antiretroviral treatment with viral load
Source: HIV Medicine - November 20, 2018 Category: Infectious Diseases Authors: G Baldin, A Ciccullo, A Capetti, S Rusconi, G Sterrantino, MV Cossu, A Giacomelli, F Lagi, A Latini, P Bagella, A De Luca, S Di Giambenedetto, G Madeddu Tags: Short Communication Source Type: research

Inequalities in HIV testing uptake and needs among men who have sex with men living in Ireland: findings from an internet survey
ConclusionsHIV prevention and testing programmes for MSM should be targeted towards younger men, those living outside Dublin and those with lower levels of education. We recommend increased promotion and availability of free HIV testing services in a range of clinical and nonclinical settings (including self ‐sampling and home testing). (Source: HIV Medicine)
Source: HIV Medicine - November 20, 2018 Category: Infectious Diseases Authors: K O'Donnell, M Fitzgerald, M Quinlan, F Hickson, P Keogh, AJ Schmidt, D McCartney, P Barrett, S O'Dea, D Igoe Tags: Original Research Source Type: research

Late diagnosis, delayed presentation and late presentation among persons enrolled in a clinical HIV cohort in Ontario, Canada (1999 –2013)
ObjectivesTimely HIV diagnosis and presentation to medical care are important for treatment and prevention. Our objective was to measure late diagnosis, delayed presentation and late presentation among individuals in the Ontario HIV Treatment Network Cohort Study (OCS) who were newly diagnosed in Ontario.MethodsThe OCS is a multi ‐site clinical cohort study of people living with HIV in Ontario, Canada. We measured prevalence of late diagnosis [CD4 count
Source: HIV Medicine - November 14, 2018 Category: Infectious Diseases Authors: J Wilton, L Light, S Gardner, B Rachlis, T Conway, C Cooper, P Cupido, CE Kendall, M Loutfy, F McGee, J Murray, J Lush, A Rachlis, W Wobeser, J Bacon, AE Kroch, M Gilbert, SB Rourke, AN Burchell, on behalf of Ontario HIV Treatment Netwo Tags: Original Research Source Type: research

Acute kidney injury in HIV ‐infected patients: a critical review
Acute kidney injury (AKI) is characterized by a rapid decline of renal function associated with worse outcomes. The purpose of the authors is to perform a critical review of the incidence, risk factors, pathogenesis and outcome of AKI in HIV ‐infected patients. Human immunodeficiency virus (HIV)‐infected patients have an increased risk of developing AKI, to which contribute both HIV‐dependent and HIV‐independent factors as well as the nephrotoxicity of drugs used. The increased risk of AKI in HIV‐infected patients and its nega tive impact on prognosis highlights the need for identification of patients at risk, cr...
Source: HIV Medicine - November 8, 2018 Category: Infectious Diseases Authors: J Gameiro, J Agapito Fonseca, S Jorge, JA Lopes Tags: Reviews in Antiretroviral Research Source Type: research

Risk of neurosyphilis in HIV ‐infected persons with syphilis lacking signs or symptoms of central nervous system infection
ConclusionsThis large number of potentially unnecessary LPs, along with heterogeneity of presentation, and the never ‐nil risk of asymptomatic neurosyphilis should be incorporated into clinical decision‐making. The majority of PLWH presenting with a serological diagnosis of syphilis, but no neurological signs or symptoms, do not necessarily require an LP for an evaluation of asymptomatic neurosyphilis. (Source: HIV Medicine)
Source: HIV Medicine - November 7, 2018 Category: Infectious Diseases Authors: L Rotman, X Luo, A Thompson, ME Mackesy ‐Amiti, LR Young, JD Young Tags: Original Research Source Type: research

Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM)
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - October 26, 2018 Category: Infectious Diseases Authors: F Li égeois, S Eymard‐Duvernay, S Boyer, G Maradan, C Kouanfack, J Domyeum, V Boyer, E Mpoudi‐Ngolé, B Spire, E Delaporte, L Vidal, C Kuaban, C Laurent, for the EVOLCAM study group, A Ambani, O Ndalle, P Momo, C Tong, L March, M Source Type: research

Shedding light on IRIS: from Pathophysiology to Treatment of Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome in HIV ‐Infected Individuals
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - October 26, 2018 Category: Infectious Diseases Authors: A Balasko, Y Keynan Source Type: research

Issue Information
HIV Medicine,Volume 19, Issue 10, Page 1-2, November 2018. (Source: HIV Medicine)
Source: HIV Medicine - October 19, 2018 Category: Infectious Diseases Source Type: research

A note of thanks to referees for Volume 19, 2018
HIV Medicine,Volume 19, Issue 10, Page 756-758, November 2018. (Source: HIV Medicine)
Source: HIV Medicine - October 19, 2018 Category: Infectious Diseases Source Type: research

Management of Renal Disease: utility of a joint HIV ‐renal clinic
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - October 15, 2018 Category: Infectious Diseases Authors: D Williams, J Scott, D Richardson, E Kingdon Source Type: research

Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - October 15, 2018 Category: Infectious Diseases Authors: YK Kiros, H Elinav, A Gebreyesus, H Gebremeskel, J Azar, D Chemtob, H Abreha, D Elbirt, E Shahar, M Chowers, D Turner, Z Grossman, A Haile, RE Sutton, SL Maayan, D Wolday Source Type: research

Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV ‐infected patients with cryptococcal meningitis
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - October 12, 2018 Category: Infectious Diseases Authors: J Chen, R Zhang, Y Shen, L Liu, T Qi, Z Wang, V Mehraj, JP Routy, H Lu Source Type: research

Risk factors for loss to follow ‐up, transfer or death among people living with HIV on their first antiretroviral therapy regimen in Mali
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - October 1, 2018 Category: Infectious Diseases Authors: A Bald é, L Lièvre, AI Maiga, F Diallo, IA Maiga, D Costagliola, S Abgrall Source Type: research

Predictors of virological failure in HIV ‐1‐infected patients switching to dolutegravir maintenance monotherapy
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - October 1, 2018 Category: Infectious Diseases Authors: IEA Wijting, SL Rutsaert, C Rokx, DM Burger, A Verbon, JJA Kampen, CAB Boucher, BJA Rijnders, L Vandekerckhove Source Type: research

Latent tuberculosis infection screening in HIV ‐infected patients: guidelines versus everyday practice in a UK HIV centre
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - October 1, 2018 Category: Infectious Diseases Authors: SJ Aston, K Doherty, B Black, G Davies Source Type: research

Coronary artery calcium and intima ‐media thickness are associated with level of cytomegalovirus immunoglobulin G in HIV‐infected patients
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - September 5, 2018 Category: Infectious Diseases Authors: A Knudsen , US Kristoffersen , I Panum , YB Hansen , PD Skottrup , P Hasbak , A Kjaer , A ‐M Lebech Source Type: research

Recurrence after hospitalization for acute coronary syndrome among HIV ‐infected and HIV‐uninfected individuals
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - September 4, 2018 Category: Infectious Diseases Authors: JL Marcus , LB Hurley , A Prasad , J Zaroff , DB Klein , MA Horberg , AS Go , GN DeLorenze , CP Quesenberry Jr , S Sidney , JC Lo , MJ Silverberg Source Type: research

Issue Information
HIV Medicine,Volume 19, Issue 9, Page 1-2, October 2018. (Source: HIV Medicine)
Source: HIV Medicine - September 3, 2018 Category: Infectious Diseases Source Type: research

HIV infection is independently associated with a higher concentration of alpha ‐1 antitrypsin
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 30, 2018 Category: Infectious Diseases Authors: RF Thudium , J Lundgren , T Benfield , BG Nordestgaard , ÁH Borges , J Gerstoft , SD Nielsen , A Ronit , on behalf of Source Type: research

Peripheral artery disease in HIV ‐infected older adults on antiretroviral treatment in Thailand
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 30, 2018 Category: Infectious Diseases Authors: L Aurpibul , P Sugandhavesa , K Srithanaviboonchai , W Sitthi , A Tangmunkongvorakul , C Chariyalertsak , K Rerkasem Source Type: research

Diagnostic performance of clinical characteristics to detect airflow limitation in people living with HIV and in uninfected controls
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 30, 2018 Category: Infectious Diseases Authors: A Ronit , T Benfield , A Mocroft , J Gerstoft , BG Nordestgaard , J Vestbo , SD Nielsen , on behalf of Source Type: research

Central obesity and nonalcoholic fatty liver disease in people living with HIV: a case for targeted screening?
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 30, 2018 Category: Infectious Diseases Authors: C Dewar , QM Anstee , DA Price , BAI Payne Source Type: research

Earlier diagnosis of HIV infection through visual HIV testing prompts
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 30, 2018 Category: Infectious Diseases Authors: K Fenton , A Cropp , M Chauhan , K Foster , J Harwood , C Lyth , DA Price , M Valappil , D Weiand Source Type: research

Longitudinal evaluation of markers of inflammation in HIV ‐positive and HIV‐negative Rwandan women
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 30, 2018 Category: Infectious Diseases Authors: EM Kiefer , DR Hoover , Q Shi , JC Dusingize , JD Sinayobye , K Anastos Source Type: research

A structural equation  model to predict pre‐exposure prophylaxis acceptability in men who have sex with men in Leicester, UK
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 30, 2018 Category: Infectious Diseases Authors: R Jaspal , B Lopes , J Bayley , P Papaloukas Source Type: research

Issue Information
HIV Medicine,Volume 19, Issue 8, Page 1-2, September 2018. (Source: HIV Medicine)
Source: HIV Medicine - August 17, 2018 Category: Infectious Diseases Source Type: research

Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96 ‐week results from two randomized clinical trials
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 13, 2018 Category: Infectious Diseases Authors: D Hagins , C Orkin , ES Daar , A Mills , C Brinson , E DeJesus , FA Post , J Morales ‐Ramirez , M Thompson , O Osiyemi , B Rashbaum , H‐J Stellbrink , C Martorell , H Liu , Y‐P Liu , D Porter , SE Collins , D SenG Source Type: research

Acceptability of high ‐resolution anoscopy for anal cancer screening in HIV‐infected patients
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 7, 2018 Category: Infectious Diseases Authors: JO Lam , GM Barnell , M Merchant , CG Ellis , MJ Silverberg Source Type: research

CD4:CD8 ratio in children with perinatally acquired HIV ‐1 infection
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - August 7, 2018 Category: Infectious Diseases Authors: T Seers , P Vassallo , K Pollock , JP Thornhill , S Fidler , C Foster Source Type: research

Interest of cytology combined with Xpert ® HPV and Anyplex® II HPV28 Detection human papillomavirus (HPV) typing: differential profiles of anal and cervical HPV lesions in HIV‐infected patients on antiretroviral therapy
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 31, 2018 Category: Infectious Diseases Authors: H Nassereddine , C Charpentier , M Bucau , V Joly , L Bienvenu , C Davitian , L Abramowitz , D Benabderrahmane , L Kotelevets , E Chastre , T Lehy , F Walker Source Type: research

Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model ‐based analysis in Switzerland
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 27, 2018 Category: Infectious Diseases Authors: K Kusejko , A Marzel , B Hampel , N Bachmann , H Nguyen , J Fehr , DL Braun , M Battegay , E Bernasconi , A Calmy , M Cavassini , M Hoffmann , J B öni , S Yerly , T Klimkait , M Perreau , A Rauch , HF Günthard , RD Source Type: research

Prevalence of diagnosed HIV infection among persons with hepatitis C virus infection: England, 2008 –2014
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 27, 2018 Category: Infectious Diseases Authors: G Ireland , V Delpech , P Kirwan , S Croxford , S Lattimore , C Sabin , K Porter , S Mandal , R Simmons Source Type: research

Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV ‐positive persons: the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) study
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 18, 2018 Category: Infectious Diseases Authors: CI Hatleberg , L Ryom , A d'Arminio Monforte , E Fontas , P Reiss , O Kirk , W El ‐Sadr , A Phillips , S de Wit , F Dabis , R Weber , M Law , JD Lundgren , C Sabin , on behalf of Source Type: research

Issue Information
HIV Medicine,Volume 19, Issue 7, Page 1-2, August 2018. (Source: HIV Medicine)
Source: HIV Medicine - July 18, 2018 Category: Infectious Diseases Source Type: research

Comparison of 48 ‐week efficacies of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and nucleoside/nucleotide reverse transcriptase inhibitor‐sparing regimens: a systematic review and network meta‐analysis
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 13, 2018 Category: Infectious Diseases Authors: S Gallien , M Massetti , P Flandre , H Leleu , D Descamps , E Lazaro Source Type: research

The role of brain biopsy in the clinical management of HIV ‐related focal brain lesions
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 13, 2018 Category: Infectious Diseases Authors: MC Acosta , M Kundro , G Viloria , A Peresin , F Morello , F Latorre , E Seoane , J Toibaro , M Losso Source Type: research

To prescribe, or not to prescribe: decision making in HIV ‐1 post‐exposure prophylaxis
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 11, 2018 Category: Infectious Diseases Authors: M Scholten , I Su árez , M Platten , T Kümmerle , N Jung , C Wyen , A Ernst , C Horn , V Burst , V Suárez , J Rybniker , G Fätkenheuer , C Lehmann Source Type: research

To T or not to T: Differences in Testosterone Use and Discontinuation by HIV Serostatus among Men who Have Sex with Men
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 10, 2018 Category: Infectious Diseases Authors: SA Haberlen , LP Jacobson , FJ Palella Jr , A Dobs , M Plankey , JE Lake , LA Kingsley , R Stall , WS Post , TT Brown Source Type: research

HIV health care providers are ready to introduce pre ‐exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 10, 2018 Category: Infectious Diseases Authors: JD Kowalska , D Bursa , D G ökengin , D Jilich , J Tomazic , M Vasylyev , P Bukovinowa , V Mulabdic , S Antonyak , A Horban , for , I. Alexiev , L. Afonina , T. Balayan , A. Bednarska , J. Begovac , E. Firląg‐Burkacka Source Type: research

Association between smoking status assessed with plasma ‐cotinine and inflammatory and endothelial biomarkers in HIV‐positive and HIV‐negative individuals
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 9, 2018 Category: Infectious Diseases Authors: MG Ahlstr öm , A Knudsen , H Ullum , J Gerstoft , A Kjaer , A‐M Lebech , P Hasbak , N Obel Source Type: research

Similar long ‐term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV‐1‐infected patients in a retrospective, real‐life cohort of 14 years
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 4, 2018 Category: Infectious Diseases Authors: I Krznaric , M Bickel , A Carganico , P De Leuw , A Haberl , G Knecht , C Koegl , P Lauscher , G Sch üttfort , C Stephan , E Wolf , T Wolf Source Type: research

Comparison of L öwenstein–Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 4, 2018 Category: Infectious Diseases Authors: J Hongler , J Musaazi , B Ledergerber , N Eberhard , C Sekaggya ‐Wiltshire , PM Keller , J Fehr , B Castelnuovo Source Type: research

Using behavioural insights to increase HIV self ‐sampling kit returns: a randomized controlled text message trial to improve England's HIV self‐sampling service
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - July 2, 2018 Category: Infectious Diseases Authors: LJ Brown , KS Tan , LE Guerra , CJ Naidoo , A Nardone Source Type: research

Liver stiffness reduction and serum fibrosis score improvement in HIV/hepatitis C virus ‐coinfected patients treated with direct‐acting antivirals
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - June 28, 2018 Category: Infectious Diseases Authors: G Fabbri , I Mastrorosa , A Vergori , L Timelli , P Lorenzini , M Zaccarelli , S Cicalini , R Bellagamba , MM Plazzi , V Mazzotta , A Antinori , A Ammassari Source Type: research

Stable HIV ‐1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study
HIV Medicine, EarlyView. (Source: HIV Medicine)
Source: HIV Medicine - June 22, 2018 Category: Infectious Diseases Authors: D Sculier , T Doco ‐Lecompte , S Yerly , KJ Metzner , LA Decosterd , A Calmy Source Type: research